Global Polio Vaccine Market Insights and Forecast to 2028

Report ID: 1153876 | Published Date: Jan 2025 | No. of Page: 91 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Polio Vaccine Product Introduction
    1.2 Market by Type
        1.2.1 Global Polio Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Inactivated Polio Vaccine (IPV)
        1.2.3 Oral Polio Vaccine (OPV)
    1.3 Market by Application
        1.3.1 Global Polio Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Public
        1.3.3 Private
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Polio Vaccine Sales Estimates and Forecasts 2017-2028
    2.2 Global Polio Vaccine Revenue Estimates and Forecasts 2017-2028
    2.3 Global Polio Vaccine Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Polio Vaccine Sales by Region
        2.4.1 Global Polio Vaccine Sales by Region (2017-2022)
        2.4.2 Global Sales Polio Vaccine by Region (2023-2028)
    2.5 Global Polio Vaccine Revenue by Region
        2.5.1 Global Polio Vaccine Revenue by Region (2017-2022)
        2.5.2 Global Polio Vaccine Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Polio Vaccine Sales by Manufacturers
        3.1.1 Global Top Polio Vaccine Manufacturers by Sales (2017-2022)
        3.1.2 Global Polio Vaccine Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Polio Vaccine in 2021
    3.2 Global Polio Vaccine Revenue by Manufacturers
        3.2.1 Global Polio Vaccine Revenue by Manufacturers (2017-2022)
        3.2.2 Global Polio Vaccine Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Polio Vaccine Revenue in 2021
    3.3 Global Polio Vaccine Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Polio Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Polio Vaccine Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Polio Vaccine Sales by Type
        4.1.1 Global Polio Vaccine Historical Sales by Type (2017-2022)
        4.1.2 Global Polio Vaccine Forecasted Sales by Type (2023-2028)
        4.1.3 Global Polio Vaccine Sales Market Share by Type (2017-2028)
    4.2 Global Polio Vaccine Revenue by Type
        4.2.1 Global Polio Vaccine Historical Revenue by Type (2017-2022)
        4.2.2 Global Polio Vaccine Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Polio Vaccine Revenue Market Share by Type (2017-2028)
    4.3 Global Polio Vaccine Price by Type
        4.3.1 Global Polio Vaccine Price by Type (2017-2022)
        4.3.2 Global Polio Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Polio Vaccine Sales by Application
        5.1.1 Global Polio Vaccine Historical Sales by Application (2017-2022)
        5.1.2 Global Polio Vaccine Forecasted Sales by Application (2023-2028)
        5.1.3 Global Polio Vaccine Sales Market Share by Application (2017-2028)
    5.2 Global Polio Vaccine Revenue by Application
        5.2.1 Global Polio Vaccine Historical Revenue by Application (2017-2022)
        5.2.2 Global Polio Vaccine Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Polio Vaccine Revenue Market Share by Application (2017-2028)
    5.3 Global Polio Vaccine Price by Application
        5.3.1 Global Polio Vaccine Price by Application (2017-2022)
        5.3.2 Global Polio Vaccine Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Polio Vaccine Market Size by Type
        6.1.1 North America Polio Vaccine Sales by Type (2017-2028)
        6.1.2 North America Polio Vaccine Revenue by Type (2017-2028)
    6.2 North America Polio Vaccine Market Size by Application
        6.2.1 North America Polio Vaccine Sales by Application (2017-2028)
        6.2.2 North America Polio Vaccine Revenue by Application (2017-2028)
    6.3 North America Polio Vaccine Market Size by Country
        6.3.1 North America Polio Vaccine Sales by Country (2017-2028)
        6.3.2 North America Polio Vaccine Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Polio Vaccine Market Size by Type
        7.1.1 Europe Polio Vaccine Sales by Type (2017-2028)
        7.1.2 Europe Polio Vaccine Revenue by Type (2017-2028)
    7.2 Europe Polio Vaccine Market Size by Application
        7.2.1 Europe Polio Vaccine Sales by Application (2017-2028)
        7.2.2 Europe Polio Vaccine Revenue by Application (2017-2028)
    7.3 Europe Polio Vaccine Market Size by Country
        7.3.1 Europe Polio Vaccine Sales by Country (2017-2028)
        7.3.2 Europe Polio Vaccine Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Polio Vaccine Market Size by Type
        8.1.1 Asia Pacific Polio Vaccine Sales by Type (2017-2028)
        8.1.2 Asia Pacific Polio Vaccine Revenue by Type (2017-2028)
    8.2 Asia Pacific Polio Vaccine Market Size by Application
        8.2.1 Asia Pacific Polio Vaccine Sales by Application (2017-2028)
        8.2.2 Asia Pacific Polio Vaccine Revenue by Application (2017-2028)
    8.3 Asia Pacific Polio Vaccine Market Size by Region
        8.3.1 Asia Pacific Polio Vaccine Sales by Region (2017-2028)
        8.3.2 Asia Pacific Polio Vaccine Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Polio Vaccine Market Size by Type
        9.1.1 Latin America Polio Vaccine Sales by Type (2017-2028)
        9.1.2 Latin America Polio Vaccine Revenue by Type (2017-2028)
    9.2 Latin America Polio Vaccine Market Size by Application
        9.2.1 Latin America Polio Vaccine Sales by Application (2017-2028)
        9.2.2 Latin America Polio Vaccine Revenue by Application (2017-2028)
    9.3 Latin America Polio Vaccine Market Size by Country
        9.3.1 Latin America Polio Vaccine Sales by Country (2017-2028)
        9.3.2 Latin America Polio Vaccine Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Polio Vaccine Market Size by Type
        10.1.1 Middle East and Africa Polio Vaccine Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Polio Vaccine Revenue by Type (2017-2028)
    10.2 Middle East and Africa Polio Vaccine Market Size by Application
        10.2.1 Middle East and Africa Polio Vaccine Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Polio Vaccine Revenue by Application (2017-2028)
    10.3 Middle East and Africa Polio Vaccine Market Size by Country
        10.3.1 Middle East and Africa Polio Vaccine Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Polio Vaccine Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Sanofi
        11.1.1 Sanofi Corporation Information
        11.1.2 Sanofi Overview
        11.1.3 Sanofi Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Sanofi Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Sanofi Recent Developments
    11.2 GSK
        11.2.1 GSK Corporation Information
        11.2.2 GSK Overview
        11.2.3 GSK Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 GSK Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 GSK Recent Developments
    11.3 Bibcol
        11.3.1 Bibcol Corporation Information
        11.3.2 Bibcol Overview
        11.3.3 Bibcol Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Bibcol Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Bibcol Recent Developments
    11.4 Serum Institute
        11.4.1 Serum Institute Corporation Information
        11.4.2 Serum Institute Overview
        11.4.3 Serum Institute Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Serum Institute Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Serum Institute Recent Developments
    11.5 Tiantan Biological
        11.5.1 Tiantan Biological Corporation Information
        11.5.2 Tiantan Biological Overview
        11.5.3 Tiantan Biological Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Tiantan Biological Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Tiantan Biological Recent Developments
    11.6 IMBCA
        11.6.1 IMBCA Corporation Information
        11.6.2 IMBCA Overview
        11.6.3 IMBCA Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 IMBCA Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 IMBCA Recent Developments
    11.7 Panacea Biotec Ltd
        11.7.1 Panacea Biotec Ltd Corporation Information
        11.7.2 Panacea Biotec Ltd Overview
        11.7.3 Panacea Biotec Ltd Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Panacea Biotec Ltd Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Panacea Biotec Ltd Recent Developments
    11.8 Bio-Med
        11.8.1 Bio-Med Corporation Information
        11.8.2 Bio-Med Overview
        11.8.3 Bio-Med Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Bio-Med Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Bio-Med Recent Developments
    11.9 Halfkin Bio-Pharmaceuticals
        11.9.1 Halfkin Bio-Pharmaceuticals Corporation Information
        11.9.2 Halfkin Bio-Pharmaceuticals Overview
        11.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Halfkin Bio-Pharmaceuticals Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Halfkin Bio-Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Polio Vaccine Industry Chain Analysis
    12.2 Polio Vaccine Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Polio Vaccine Production Mode & Process
    12.4 Polio Vaccine Sales and Marketing
        12.4.1 Polio Vaccine Sales Channels
        12.4.2 Polio Vaccine Distributors
    12.5 Polio Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Polio Vaccine Industry Trends
    13.2 Polio Vaccine Market Drivers
    13.3 Polio Vaccine Market Challenges
    13.4 Polio Vaccine Market Restraints
14 Key Findings in The Global Polio Vaccine Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Polio Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Inactivated Polio Vaccine (IPV)
    Table 3. Major Manufacturers of Oral Polio Vaccine (OPV)
    Table 4. Global Polio Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Polio Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Polio Vaccine Sales by Region (2017-2022) & (M Doses)
    Table 7. Global Polio Vaccine Sales Market Share by Region (2017-2022)
    Table 8. Global Polio Vaccine Sales by Region (2023-2028) & (M Doses)
    Table 9. Global Polio Vaccine Sales Market Share by Region (2023-2028)
    Table 10. Global Polio Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Polio Vaccine Revenue Market Share by Region (2017-2022)
    Table 12. Global Polio Vaccine Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Polio Vaccine Revenue Market Share by Region (2023-2028)
    Table 14. Global Polio Vaccine Sales by Manufacturers (2017-2022) & (M Doses)
    Table 15. Global Polio Vaccine Sales Share by Manufacturers (2017-2022)
    Table 16. Global Polio Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Polio Vaccine Revenue Share by Manufacturers (2017-2022)
    Table 18. Polio Vaccine Price by Manufacturers (2017-2022) &(USD/K Doses)
    Table 19. Global Polio Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Polio Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polio Vaccine as of 2021)
    Table 21. Polio Vaccine Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Polio Vaccine Product Offered
    Table 23. Date of Manufacturers Enter into Polio Vaccine Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Polio Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 26. Global Polio Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 27. Global Polio Vaccine Sales Share by Type (2017-2022)
    Table 28. Global Polio Vaccine Sales Share by Type (2023-2028)
    Table 29. Global Polio Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Polio Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Polio Vaccine Revenue Share by Type (2017-2022)
    Table 32. Global Polio Vaccine Revenue Share by Type (2023-2028)
    Table 33. Polio Vaccine Price by Type (2017-2022) & (USD/K Doses)
    Table 34. Global Polio Vaccine Price Forecast by Type (2023-2028) & (USD/K Doses)
    Table 35. Global Polio Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 36. Global Polio Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 37. Global Polio Vaccine Sales Share by Application (2017-2022)
    Table 38. Global Polio Vaccine Sales Share by Application (2023-2028)
    Table 39. Global Polio Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Polio Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Polio Vaccine Revenue Share by Application (2017-2022)
    Table 42. Global Polio Vaccine Revenue Share by Application (2023-2028)
    Table 43. Polio Vaccine Price by Application (2017-2022) & (USD/K Doses)
    Table 44. Global Polio Vaccine Price Forecast by Application (2023-2028) & (USD/K Doses)
    Table 45. North America Polio Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 46. North America Polio Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 47. North America Polio Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Polio Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Polio Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 50. North America Polio Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 51. North America Polio Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Polio Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Polio Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 54. North America Polio Vaccine Sales by Country (2023-2028) & (M Doses)
    Table 55. North America Polio Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Polio Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Polio Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 58. Europe Polio Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 59. Europe Polio Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Polio Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Polio Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 62. Europe Polio Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 63. Europe Polio Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Polio Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Polio Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 66. Europe Polio Vaccine Sales by Country (2023-2028) & (M Doses)
    Table 67. Europe Polio Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Polio Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Polio Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 70. Asia Pacific Polio Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 71. Asia Pacific Polio Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Polio Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Polio Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 74. Asia Pacific Polio Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 75. Asia Pacific Polio Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Polio Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Polio Vaccine Sales by Region (2017-2022) & (M Doses)
    Table 78. Asia Pacific Polio Vaccine Sales by Region (2023-2028) & (M Doses)
    Table 79. Asia Pacific Polio Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Polio Vaccine Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Polio Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 82. Latin America Polio Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 83. Latin America Polio Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Polio Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Polio Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 86. Latin America Polio Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 87. Latin America Polio Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Polio Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Polio Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 90. Latin America Polio Vaccine Sales by Country (2023-2028) & (M Doses)
    Table 91. Latin America Polio Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Polio Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Polio Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 94. Middle East and Africa Polio Vaccine Sales by Type (2023-2028) & (M Doses)
    Table 95. Middle East and Africa Polio Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Polio Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Polio Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 98. Middle East and Africa Polio Vaccine Sales by Application (2023-2028) & (M Doses)
    Table 99. Middle East and Africa Polio Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Polio Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Polio Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 102. Middle East and Africa Polio Vaccine Sales by Country (2023-2028) & (M Doses)
    Table 103. Middle East and Africa Polio Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Polio Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Sanofi Corporation Information
    Table 106. Sanofi Description and Major Businesses
    Table 107. Sanofi Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 108. Sanofi Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Sanofi Recent Developments
    Table 110. GSK Corporation Information
    Table 111. GSK Description and Major Businesses
    Table 112. GSK Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 113. GSK Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. GSK Recent Developments
    Table 115. Bibcol Corporation Information
    Table 116. Bibcol Description and Major Businesses
    Table 117. Bibcol Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 118. Bibcol Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Bibcol Recent Developments
    Table 120. Serum Institute Corporation Information
    Table 121. Serum Institute Description and Major Businesses
    Table 122. Serum Institute Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 123. Serum Institute Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Serum Institute Recent Developments
    Table 125. Tiantan Biological Corporation Information
    Table 126. Tiantan Biological Description and Major Businesses
    Table 127. Tiantan Biological Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 128. Tiantan Biological Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Tiantan Biological Recent Developments
    Table 130. IMBCA Corporation Information
    Table 131. IMBCA Description and Major Businesses
    Table 132. IMBCA Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 133. IMBCA Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. IMBCA Recent Developments
    Table 135. Panacea Biotec Ltd Corporation Information
    Table 136. Panacea Biotec Ltd Description and Major Businesses
    Table 137. Panacea Biotec Ltd Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 138. Panacea Biotec Ltd Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Panacea Biotec Ltd Recent Developments
    Table 140. Bio-Med Corporation Information
    Table 141. Bio-Med Description and Major Businesses
    Table 142. Bio-Med Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 143. Bio-Med Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Bio-Med Recent Developments
    Table 145. Halfkin Bio-Pharmaceuticals Corporation Information
    Table 146. Halfkin Bio-Pharmaceuticals Description and Major Businesses
    Table 147. Halfkin Bio-Pharmaceuticals Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
    Table 148. Halfkin Bio-Pharmaceuticals Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Halfkin Bio-Pharmaceuticals Recent Developments
    Table 150. Key Raw Materials Lists
    Table 151. Raw Materials Key Suppliers Lists
    Table 152. Polio Vaccine Distributors List
    Table 153. Polio Vaccine Customers List
    Table 154. Polio Vaccine Market Trends
    Table 155. Polio Vaccine Market Drivers
    Table 156. Polio Vaccine Market Challenges
    Table 157. Polio Vaccine Market Restraints
    Table 158. Research Programs/Design for This Report
    Table 159. Key Data Information from Secondary Sources
    Table 160. Key Data Information from Primary Sources
List of Figures
    Figure 1. Polio Vaccine Product Picture
    Figure 3. Global Polio Vaccine Market Share by Type in 2021 & 2028
    Figure 3. Inactivated Polio Vaccine (IPV) Product Picture
    Figure 4. Oral Polio Vaccine (OPV) Product Picture
    Figure 5. Global Polio Vaccine Market Share by Application in 2021 & 2028
    Figure 6. Public
    Figure 7. Private
    Figure 8. Polio Vaccine Report Years Considered
    Figure 9. Global Polio Vaccine Sales 2017-2028 (M Doses)
    Figure 10. Global Polio Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Polio Vaccine Revenue 2017-2028 (US$ Million)
    Figure 12. Global Polio Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 13. Global Polio Vaccine Sales Market Share by Region (2017-2022)
    Figure 14. Global Polio Vaccine Sales Market Share by Region (2023-2028)
    Figure 15. North America Polio Vaccine Sales YoY (2017-2028) & (M Doses)
    Figure 16. North America Polio Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 17. Europe Polio Vaccine Sales YoY (2017-2028) & (M Doses)
    Figure 18. Europe Polio Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Asia-Pacific Polio Vaccine Sales YoY (2017-2028) & (M Doses)
    Figure 20. Asia-Pacific Polio Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Latin America Polio Vaccine Sales YoY (2017-2028) & (M Doses)
    Figure 22. Latin America Polio Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Middle East & Africa Polio Vaccine Sales YoY (2017-2028) & (M Doses)
    Figure 24. Middle East & Africa Polio Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. The Polio Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 26. The Top 5 and 10 Largest Manufacturers of Polio Vaccine in the World: Market Share by Polio Vaccine Revenue in 2021
    Figure 27. Global Polio Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 28. Global Polio Vaccine Sales Market Share by Type (2017-2028)
    Figure 29. Global Polio Vaccine Revenue Market Share by Type (2017-2028)
    Figure 30. Global Polio Vaccine Sales Market Share by Application (2017-2028)
    Figure 31. Global Polio Vaccine Revenue Market Share by Application (2017-2028)
    Figure 32. North America Polio Vaccine Sales Market Share by Type (2017-2028)
    Figure 33. North America Polio Vaccine Revenue Market Share by Type (2017-2028)
    Figure 34. North America Polio Vaccine Sales Market Share by Application (2017-2028)
    Figure 35. North America Polio Vaccine Revenue Market Share by Application (2017-2028)
    Figure 36. North America Polio Vaccine Sales Share by Country (2017-2028)
    Figure 37. North America Polio Vaccine Revenue Share by Country (2017-2028)
    Figure 38. U.S. Polio Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 39. Canada Polio Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 40. Europe Polio Vaccine Sales Market Share by Type (2017-2028)
    Figure 41. Europe Polio Vaccine Revenue Market Share by Type (2017-2028)
    Figure 42. Europe Polio Vaccine Sales Market Share by Application (2017-2028)
    Figure 43. Europe Polio Vaccine Revenue Market Share by Application (2017-2028)
    Figure 44. Europe Polio Vaccine Sales Share by Country (2017-2028)
    Figure 45. Europe Polio Vaccine Revenue Share by Country (2017-2028)
    Figure 46. Germany Polio Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 47. France Polio Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 48. U.K. Polio Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 49. Italy Polio Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 50. Russia Polio Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 51. Asia Pacific Polio Vaccine Sales Market Share by Type (2017-2028)
    Figure 52. Asia Pacific Polio Vaccine Revenue Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Polio Vaccine Sales Market Share by Application (2017-2028)
    Figure 54. Asia Pacific Polio Vaccine Revenue Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Polio Vaccine Sales Share by Region (2017-2028)
    Figure 56. Asia Pacific Polio Vaccine Revenue Share by Region (2017-2028)
    Figure 57. China Polio Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 58. Japan Polio Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 59. South Korea Polio Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 60. India Polio Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 61. Australia Polio Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 62. Taiwan Polio Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 63. Indonesia Polio Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 64. Thailand Polio Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 65. Malaysia Polio Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 66. Philippines Polio Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 67. Latin America Polio Vaccine Sales Market Share by Type (2017-2028)
    Figure 68. Latin America Polio Vaccine Revenue Market Share by Type (2017-2028)
    Figure 69. Latin America Polio Vaccine Sales Market Share by Application (2017-2028)
    Figure 70. Latin America Polio Vaccine Revenue Market Share by Application (2017-2028)
    Figure 71. Latin America Polio Vaccine Sales Share by Country (2017-2028)
    Figure 72. Latin America Polio Vaccine Revenue Share by Country (2017-2028)
    Figure 73. Mexico Polio Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 74. Brazil Polio Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 75. Argentina Polio Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 76. Middle East and Africa Polio Vaccine Sales Market Share by Type (2017-2028)
    Figure 77. Middle East and Africa Polio Vaccine Revenue Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Polio Vaccine Sales Market Share by Application (2017-2028)
    Figure 79. Middle East and Africa Polio Vaccine Revenue Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Polio Vaccine Sales Share by Country (2017-2028)
    Figure 81. Middle East and Africa Polio Vaccine Revenue Share by Country (2017-2028)
    Figure 82. Turkey Polio Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 83. Saudi Arabia Polio Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 84. U.A.E Polio Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 85. Polio Vaccine Value Chain
    Figure 86. Polio Vaccine Production Process
    Figure 87. Channels of Distribution
    Figure 88. Distributors Profiles
    Figure 89. Bottom-up and Top-down Approaches for This Report
    Figure 90. Data Triangulation
    Figure 91. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Frequently Asked Questions
Polio Vaccine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Polio Vaccine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Polio Vaccine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Helium Leak Sensor

Helium Leak Sensor market is segmented by Type and by Application. Players, stakeholders, and oth ... Read More

Zinc Citrate

Zinc Citrate market is segmented by Type and by Application. Players, stakeholders, and other par ... Read More

Haptics Technology

Haptics Technology market is segmented by players, region (country), by Type and by Application.  ... Read More